共 151 条
- [1] Finkel RS(2018)Diagnosis and management of spinal muscular atrophy: Part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics Neuromuscul Disord 28 197-207
- [2] Mercuri E(2012)Childhood spinal muscular atrophy: controversies and challenges Lancet Neurol 11 443-452
- [3] Meyer OH(2004)Respiratory capacity course in patients with infantile spinal muscular atrophy Chest 126 831-837
- [4] Simonds AK(2013)Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3 Eur J Paediatr Neurol. 17 552-60
- [5] Schroth MK(2021)Respiratory trajectories in type 2 and 3 spinal muscular atrophy in the iSMAC cohort study Neurology 96 e587-e599
- [6] Graham RJ(2022)Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study Orphanet J Rare Dis. 17 70-e1644
- [7] Mercuri E(2020)Natural history of lung function in spinal muscular atrophy Orphanet J Rare Dis 15 88-40
- [8] Bertini E(2020)Population-based analysis of survival in spinal muscular atrophy Neurology 94 e1634-339
- [9] Iannaccone ST(2012)Guideline for respiratory management of children with neuromuscular disease Thorax 67 1-367
- [10] Ioos C(2018)Precious SMA natural history data: a benchmark to measure future treatment successes Neurology 91 337-523